Gene Editing, Gene Silencing, & CRISPR
News on CRISPR, gene editing, RNAi in genetics, genomics, and molecular diagnostics.
Digital PCR's strengths make the technology well positioned to aid biopharma companies in cell and gene therapy development and manufacturing.
The Chinese firm has developed a genome engineering tool to precisely insert large DNA fragments into plant genomes in order to develop desirable traits in crops.
Bristol Myers Squibb, Medic Life Sciences Collaborate on Tumor Target Discovery
Medic will receive upfront payments and will be eligible for additional option payments, as well as future development and regulatory milestone payments.
ERS Genomics, Applied Biological Materials Ink Gene Editing Licensing Agreement
The nonexclusive agreement will allow Applied Biological Materials to develop and commercialize products using ERS’s CRISPR-Cas9 patent portfolio.
US Patent Office Invalidates Two Agilent Technologies Patents Covering CRISPR Guide RNAs
Synthego, an Agilent competitor in the gene editing market, had initiated an inter partes review in January 2022 as part of a plan to ward off patent infringement allegations.